[The cytoprotective effect of prostaglandin E2 in duodenal ulcers].
Intragastric administration of a synthetic analog of prostaglandin E2 to patients with duodenal ulcers results in depression of the gastric acid production and in reduction of potassium level, leads to an elevation of the sialic acid debit and a rise of sodium concentration, not essentially changing calcium, chlorides, and pepsin levels. A combined analysis of gastric acid production and measurements of sialic acids, sodium and potassium detect the imbalance of the mucoid and bicarbonate secretion in peptic ulcers, this helping predict the disease course.
Skliarov
E Ia
EIa
Panasiuk
E N
EN
Skliarov
A Ia
AIa
D000293:Adolescent; D000328:Adult; D000368:Aged; D015232:Dinoprostone / Q000627:therapeutic use*; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D004573:Electrolytes / Q000032:analysis; D005260:Female; D005744:Gastric Acid / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010434:Pepsin A / Q000032:analysis
D004573:Electrolytes; D010434:Pepsin A; D015232:Dinoprostone
Tsitoprotektivnoe deĭstvie prostaglandina E2 pri iazvennoĭ bolezni.